Search

For centuries, research has been conducted on the therapeutics of Brassicaceae plants and their health-promoting effects. Cato the Elder (234-149 BCE) documented their properties in his work De agri cultura and recommended using cabbage to compress wounds, swelling, burns, and bone dislocations. For arthritis, he recommended chopped raw cabbage mixed with coriander and cured cabbage mixed with vinegar and honey. In a groundbreaking discovery in the 1990s, scientists at Johns Hopkins University isolated sulforaphane from broccoli, revealing its potent anticancer properties. This naturally occurring compound has proven highly effective, safe, and tolerable and holds immense promise as a chemoprevention agent. It has the potential to combat various cancers, including breast, prostate, gastrointestinal, melanoma, lung, brain, and bladder. But its potential does not stop there. It also shows promise in treating cardiovascular and neurodegenerative diseases and diabetes, offering hope for those affected. The cancer-protecting properties of Brassica plants are mediated through compounds that induce a variety of physiological processes, including antioxidant action, detoxifying enzymes, inducing apoptosis, and cell cycle regulation. Glucosinolate breakdown products can affect several stages of cancer development, including the inhibition of activation enzymes (phase I) and the induction of detoxification enzymes (phase II). Isothiocyanates and indole products formed from glucosinolates regulate cancer cell development by regulating target enzymes, controlling apoptosis, inhibiting angiogenesis, metastasis, and the migration of cancer cells, and blocking the cell cycle. Sulforaphane, found in abundance in broccoli sprouts, plays a crucial role in upregulating the transcriptional activity of specific genes and restoring epigenetic alterations. This is particularly significant as it modifies epigenetic pathways by targeting histone deacetylases and DNA methyltransferases. These modifications, in turn, alter gene transcription and expression, particularly in the case of cancers. This intricate process of gene regulation is a fascinating study area, making broccoli sprouts a compelling component of the'epigenetic diet.'Sulforaphane induces the cytoprotective enzyme NQO1. The inducible expression of NQO1 is regulated principally through the Keap1-Nrf2-ARE signaling pathway. The activation of the Nrf2-Keap1 signaling pathway heralds the beneficial actions of drugs known to affect Nrf2 signaling, such as dimethyl fumarate, an FDA-approved treatment for multiple sclerosis, and bardoxolone methyl for chronic kidney disease. There is optimism that the overall strategies are moving forward. Sulforaphane-rich broccoli sprout extracts provide one avenue toward this end.

Since 1972, which marks the invention of recombinant engineering, more than 500 therapeutic proteins have been approved for clinical use. Today, biological drugs constitute almost 70% of all new drugs and have a biological origin. The first edition of this book dealt with biosimilars, and this edition (i.e., the second edition) focuses on new drugs, yet limits to therapeutic proteins. Newer technologies for drug development represent the updated topics in the book and include repur-posing, AI- driven identification of newer designs, novel expression systems, manufacturing using these systems, rapidly changing regulatory pathways, and legal hurdles. This edition discusses how to identify, develop, manufacture, and take multibillion dollar products to market within the shortest possible time.Features: Complete and thorough coverage of the regulatory and technological challenges of developing generic therapeutic proteins Comprehensive, discovery to market, newer technologies, regulatory planning and IP hurdles are included that are not found elsewhere Expanded volume that must be in the hands of every company interested in biological drugs, including the mRNA-based biopharmaceutical companies fast appearing on the market Discusses how to identify, develop, manufacture, and take multibillion dollar products to market in the shortest possible time Renowned author and entrepreneur in the field of drug discovery and production

Der Arzneiverordnungs-Report ist seit 1985 eine gemeinsame Publikation von Autoren aus Pharmakologie, Klinik, Praxis, Gesundheitsökonomie und Krankenversicherung. Basis sind die Verordnungsdaten von Arzneimitteln für ambulante Patienten der gesetzlichen Krankenversicherung (GKV).

This dictionary of toxicology provides curated and authentic information on the terminologies used with their description as per modern toxicology and associated declines. It aims to have a collection of over 3500 terminologies with their basic information and roles with relevance in toxicology and associated disciplines in alphabetical order. This book has a flow of information in alphabetical order starting from word A to Z. The contents cover all the possible facets of contemporary. It is an unparalleled reservoir of information with a practical understanding of the subject for undergraduates, post-graduate, doctorate and post-doctorate, researchers of toxicology, medical and dental sciences, veterinary sciences, pharmacy sciences, life sciences, forensic sciences, etc. Besides this, target readers would also be personnel working in academia, pharma industries, contract research organizations involved in regulatory studies, regulatory agencies and implementing agencies, and people having an interest in toxicological sciences.

Der Arzneiverordnungs-Report ist seit 1985 eine gemeinsame Publikation von Autoren aus Pharmakologie, Klinik, Praxis, Gesundheitsökonomie und Krankenversicherung. Basis sind die Verordnungsdaten von Arzneimitteln für ambulante Patienten der gesetzlichen Krankenversicherung (GKV).

More detailed than an outlined review but less overwhelming than an encyclopedic reference, Brenner and Stevens'Pharmacology, 6th Edition, focuses on the essential principles you need to know in a concise, easy-to-understand manner. Authored by Craig W. Stevens, PhD, this highly illustrated introductory text helps you learn and retain key information in pharmacology—taking you from course exams and the USMLE Step 1 right through to clinical practice. New and extensively revised content keeps you up to date with the latest pharmacologic mechanisms and applications. - Teaches the fundamental aspects of pharmacology using full-color illustrations, detailed explanations, and a consistent format to present classification of drugs for each system/disease. - Helps you understand both the basic science foundations and clinical applications of pharmacology, with useful tables, drug classifications boxes, case studies, and self-assessments in each chapter to help you review and prepare for course exams and Step 1. - Includes the latest drugs and therapeutic indications (more than 100 are new to this edition), along with an entirely new chapter on recent developments of immunopharmacology drugs, including antivirals and vaccinations. - Addresses key topics such as antiviral and monoclonal drugs to treat COVID-19, the opioid epidemic, and gene therapy. - Features more than 700 new and updated images, with many revised figures focused on clearing presenting the mechanism of action of drugs. - Includes access to bonus eBook content such as animations, an additional glossary, chapter-by-chapter summaries and case studies, a full list of featured drugs, 150 USMLE-style self-assessment questions, and more.

Medical Pharmacology & Therapeutics provides all the information medical and healthcare students need throughout their degree programme and beyond, including for professional qualifications such as the PSA. This all-round textbook covers basic pharmacology through to drug prescribing in clinical contexts, covering the pathogenic mechanisms of disease; drug actions, side effects, and the therapeutic principles of drug use. It takes a helpful systems-based approach that orders information according to body systems and disease areas, rather than by drug class. Now in its sixth edition, the book has been fully updated to include latest scientific understanding of drug action and administration and current best practice in prescribing medications, informed by the latest national guidelines. - A clinical focus throughout – suitable for medical, nursing and other healthcare students throughout their training - Thorough update of clinically-relevant medicines to ensure best practice - Information aligned with the British National Formulary (BNF), NICE guidelines and relevant professional benchmarks - Comprehensive drug compendia allow all drugs to be identified and placed within their respective classes - Extensive self-assessment questions to support learning and revision - New to this edition Expanded discussion of the pathophysiology and management of shock - Revised discussion of the management of chronic pain - Consideration of treatment of Covid-19 - Expanded discussion of the pathophysiology and management of shock - Revised discussion of the management of chronic pain - Consideration of treatment of Covid-19

Drugs in Sport is the most comprehensive and accurate text on the emotive, complex and critical subject of performance enhancement and doping within sport. Thoroughly updated in light of the latest World Anti-Doping Code and taking into account the latest regulations, procedures and landmark cases, this 8th edition explores the science behind drug use in sport, as well as its ethical, social, political and administrative context. Introducing an increased focus on athletes with specific needs and on corrupt doping practices, the book covers key topics including:- an evaluation of the prevalence of doping in sport; - the latest doping control regulations stipulated by the World Anti-Doping Agency (WADA); - the science and side effects of each major class of drug used in sport;- cutting-edge issues such as drug use by transgender athletes; - medical and anti-doping considerations for athletes with an impairment;- governance and corruption in sport including institutionalised doping;- issues surrounding sport nutrition and supplement use in sport; - medical and pharmaceutical services at major sporting events. Accessibly written, and supported throughout with illustrative case studies and data, Drugs in Sport provides a crucial and objective resource for students and researchers, athletes, sports scientists, coaches and athlete-support staff, journalists, sports administrators and policymakers, alike.

The British National Formulary (BNF) is the first choice for concise medicines information. Trusted by healthcare professionals across the world to support confident decision-making at the point of care. The new edition (BNF 83) provides up-to-date guidance on prescribing, dispensing, and administering medicines, plus legal and professional guidelines.

Fundamentals of Pharmacology is primarily a text for undergraduate and postgraduate students in the health science disciplines, particularly those in nursing. It is designed to establish a foundational knowledge of pharmacology - the study of drug and medication actions and interactions. Students of other health disciplines whose roles involve pharmacological therapy (such as pharmacy, podiatry, optometry, paramedic and physiotherapy), as well as those studying basic science, should find much of the material relevant to their studies. Qualified health professionals may also find this textbook useful as a part of their continuing professional education and postgraduate studies. Philosophically, our goal is to empower health professionals through an understanding of the fundamental scientific principles of pharmacology that inform clinical practice. To promote understanding, we believe that the effects of medicines on physiological and pathophysiological processes have to be clearly explained. We have included a small amount of chemistry and biochemistry where appropriate to facilitate this understanding. With a greater appreciation of the action of medicines and their target tissues, the reader should be able to deduce what therapeutic and adverse effects to expect, as well as the precautions and contraindications to consider. We have sought to balance the pharmacology content with considerations associated with clinical practice in the most readable way. Where possible, we have tended to describe the important characteristics of medicine groupings rather than focus on individual agents. We have used prototypes and common generics as examples. The rationale for this approach is that new medicines are regularly entering the market while older agents are removed. The average practitioner cannot possibly keep up with all these changes. However, if a student knows which grouping a new agent belongs to, the principal characteristics of the medicine can be easily deduced. Samples Download the table of contents Preview sample pages from Fundamentals of Pharmacology Features Concept maps - Shows the links between the pharmacology and pathophysiology of common conditions Specific icons - Visual ways to identify whether medicines are available in Australia and/or New Zealand Clinical management boxes - Highlights clinical applications of theory and uses the clinal decision-making framework in a step-by-step process for care of the person Case studies - Gives students the opportunity to apply theoretical knowledge to real-world scenarios in a low-stakes environment, thereby developing important critical thinking and analysis skills. Review questions - Consolidation of student's learning New to this edition Pearson eText - Allowing flexibility and choice for learners in how they would like to learn. With Bullock being such a large text, students can choose to buy the digital version for ease and simplicity on the move. Framework change: Focuses on a body systems approach - A systems approach in nursing is one that organises health assessment around different body systems, such as cardiac, respiratory, neurological, gastrointestinal, urinary, and musculoskeletal systems. Moving to a systems-based approach will help students navigate the content easier and find what they need more quickly. New section - Inflammation, immunity and cancer - Content and flow fit better within this new section allowing for a better learning experience for the learner. Streamlining o

The new revised fourth edition of Drug Handbook in Obstetrics and Gynaecology, which has been your favourite over the last 22 years, making it a consistent bestseller. Every effort has been made to make it up-to-date and friendly as in previous editions.

Before now, biological systems could only be expressed in terms of linear relationships, however, as knowledge grows and new techniques of analysis on biological systems is made available, we are realizing the non-linearity of these systems. The concepts and techniques of nonlinear analysis allow for more realistic and accurate models in science. The Future of Pharmaceuticals: A Nonlinear Analysis provides an opportunity to understand the non-linearity of biological systems and its application in various areas of science, primarily pharmaceutical sciences. This book will benefit professionals in pharmaceutical industries, academia, and policy who are interested in an entirely new approach to how we will treat disease in the future.Key Features: Addresses a new approach of nonlinear analysis. Applies a theory of projection to chalk out the future, instead of basing on linear evolution. Provides an opportunity to better understand the non-linearity in biological systems and its applications in various areas of science, primarily pharmaceutical sciences. Helps change the thought process for those looking for answers to their questions which they do not find in the linear relationship approach. Encourages a broader perspective for the creative process of drug development.

Comprehensive Pharmacology, Seven Volume Set is organized into twelve sections that explore therapeutic areas, with a total of 320 comprehensive articles and 6,800 pages of important findings. Sections contain highly detailed coverage of information that has been overseen by an editorial board made up of well-respected, field leading experts. The content in this book offers readers an in-depth and easily accessible reference work on every aspect of pharmacological research surrounding the pharmacology of all therapeutic applications of drugs, their mechanism of action and their therapeutic values. These elements are essential as drugs are almost never tested and developed in the actual therapeutic system, but rather in test systems from which parameters must be determined to predict activity in systems of varying ambient physiology. As different technologies rapidly evolve, there is an ever-increasing level of knowledge about the pharmacology of known drugs, along with increasing capability to utilize pharmacological systems to predict new drug activity, all of which must be communicated to professionals in varying fields. - Contains chapters that follow a consistent and templated approach, resulting in well-structured content that enhances user experience and appeal - Offers a comprehensive review on a wealth of information on pharmacology and how it utilizes concepts and techniques from a broad array of sciences, ranging from chemistry to physiology to medicine - Includes a wider use of color and multimedia content, with interactive features, links, computational modeling and animations to illustrate the effects of toxic substances in various contexts

This open access book presents the history, pharmacokinetics and pharmacodynamics of levothyroxine, discussing its role in the thyroid pathophysiology of patients of various ages and during pregnancy. It also describes the influence of levothyroxine on heart, bone and in cancer. When it was first synthesized in 1949, levothyroxine represented a significant advance in the treatment of hypothyroidism, providing a safe and effective treatment option for millions of hypothyroid patients around the globe. This synthetic form of thyroxine is now one of the most prescribed drugs in the world. Levothyroxine was first introduced by Merck KGaA,Darmstadt, Germany, in 1972, and since then the company has remained actively engaged in research on this mainstay of hypothyroidism treatment. This book is intended for healthcare professionals.

Pour comprendre le mode d'action des médicaments, leur utilité et leurs dangers pendant la grossesse, et assumer en pleine autonomie la responsabilité de la grossesse normale et de l'accouchement eutocique. Ce livre est un outil indispensable dans la prescription des médicaments de la grossesse, de l'accouchement et de la post-natalité. Il propose : - un classement des médicaments par systèmes, - des rappels physiopathologiques au début de chaque chapitre, - le mode d'action des médicaments, leurs indications et leurs risques, - des encadrés pratiques sur l'utilisation des médicaments pendant la grossesse et l'allaitement, - un index des médicaments par DCI, pour trouver plus facilement l'information recherchée. Cette 4e édition a été mise à jour avec la liste des médicaments prescriptibles par les sage- femmes en France et en Belgique.

This book is for personalized medicine as a prescription of specific treatments and therapeutics best suited for an individual and considers genetic as well as environmental factors that influence responses to therapy. Best approaches are described for integration of all available technologies for optimizing the therapy of individual patients. This comprehensive third edition covers the latest advances in personalized medicine and several chapters are devoted to various specialties, particulary cancer which is the largest area of application. The book discusses the development of personalized medicine and various players in it such as companies, academic institutions, the government, and the public as the consumer of healthcare. Additionally, the roles of bioinformatics, electronic health records, and digital technologies for personalized medicine are discussed. Textbook of Personalized Medicine, 3rd Edition serves as a convenient source of informationfor students at many levels and in a wide range of fields, including physicians, scientists, and decision makers in the biopharmaceutical and healthcare industries.

Der Arzneiverordnungs-Report ist seit 1985 eine gemeinsame Publikation von Autoren aus Pharmakologie, Klinik, Praxis, Gesundheitsökonomie und Krankenversicherung. Basis sind die Verordnungsdaten von Arzneimitteln für ambulante Patienten der gesetzlichen Krankenversicherung (GKV). Datenbasis des Jahres 2020 sind ca. 820 Mio. Verordnungen von 150.363 Vertragsärzten und 62.876 Vertragszahnärzten für 73,4 Mio. GKV-Versicherte. Die allgemeine Verordnungs- und Marktentwicklung wird in 6 Kapiteln behandelt, in denen u.a. neue Arzneimittel des Jahres 2020, die Kosten-Nutzen-Analyse von onkologischen Arzneimitteln, Marktsteuerungsmechanismen und Preise von Biologika bzw. Biosimilars sowie die Klassifizierung von Arzneistoffgruppen diskutiert werden.Die Nettokosten für Arzneimittel in der GKV sind 2020 weiter um 5% auf rund 46 Mrd. € gestiegen, vor allem durch neue, hochpreisige Patentarzneimittel. Hauptkostentreiber waren Onkologika (9,5 Mrd. €, + 12,4%)und Antidiabetika (2,8 Mrd. €, + 16,8%). Ein wesentlicher Grund für die Kostenprobleme ist der seit Jahren beobachtete Anstieg der Jahrestherapiekosten neu eingeführter Arzneimittel. Dieser Trend zu hochpreisigen Patentarzneimitteln ist durch das Arzneimittelmarktneuordnungsgesetz (AMNOG) sogar 10 Jahre nach seiner Einführung nicht genügend abgeschwächt worden, auch wenn mit der Vereinbarung von Erstattungsbeträgen 2020 insgesamt 3,7 Mrd. € an Einsparungen erzielt werden konnten.

Advances in Pharmacology series, highlights new advances in the field, with this new volume presenting interesting chapters. Each chapter is written by an international board of authors. - Provides the authority and expertise of leading contributors from an international board of authors - Presents the latest release in Advances in Pharmacology series - Updated release includes the latest information on Endocrine-Disrupting Chemicals

This book will focus on the harmful effect of environmental toxins on female reproductive health. Reproduction is the basis of the continuation of human beings, and environment is the basis of human survival. However, environmental pollution has become a potential risk factor for human reproductive health, which not only leads to many chronic diseases, but also causes certain harm to reproductive health. Compared to male reproduction, female reproductive process is more complex, the reproductive system is more fragile, and is more vulnerable to be damaged. The aim of this book is to review the research progress, to address the challenges, and to stimulate the development in the direction of environment and female reproductive health.

The British National Formulary (BNF) is the first choice for concise medicines information. Trusted by healthcare professionals across the world to support confident decision-making at the point of care. The new edition (BNF 81) provides up-to-date guidance on prescribing, dispensing, and administering medicines, plus legal and professional guidelines.

To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications.This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types.Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function.

Lanzkowsky's Manual of Pediatric Hematology and Oncology, Seventh Edition remains the go-to clinical manual for the treatment and management of childhood cancers and blood disorders. It is a comprehensive book on patient management, replete with algorithms and flow diagrams, and includes a new section on vascular anomalies. Reflecting the considerable advances in the treatment and management of hematologic and oncologic diseases in children, the seventh edition of this successful clinical manual is entirely updated to incorporate all current treatment protocols, new drugs, and management approaches. Its concise and easy-to-read format, again, enables readers to make accurate diagnoses and treatment decisions without having to reference larger medical textbooks. - Designed to be easily readable and highly practical with over 400 illustrative tables, along with color diagrams and figures - New chapter on Pediatric Vascular Anomalies - New content on'blood avoidance'programs to honor religious preferences - Discussions of new drugs and immunological therapies for cancers, along with discussions of increasing use of cytokine stimulants for hematologic disorders - Includes practical genetic evaluations providing a deeper understanding and advances in management of bone marrow failure diseases

Trusted by healthcare professionals across the world to support confident decision-making at the point of care. The new edition provides up-to-date guidance on prescribing, dispensing, and administering medicines to children, plus legal and professional guidelines. Recommendations in the BNF for Children have been constructed on the basis of authoritative sources, emerging evidence, best practice guidelines and advice from a network of paediatric experts. The process is overseen by a paediatric formulary committee.

The British National Formulary (BNF) is the first choice for concise medicines information. Trusted by healthcare professionals across the world to support confident decision-making at the point of care. The new edition (BNF 80) provides up-to-date guidance on prescribing, dispensing, and administering medicines, plus legal and professional guidelines.

This volume provides readers with the most updated scientific information on the efficacy and safety of medicines for children and adolescents. The book enriches the understanding of pediatric pharmacotherapy for health professionals, regulatory agencies, pharmaceutical companies and learned societies. It contains important information on the pharmacodynamics and pharmacokinetics of drugs. It summarizes the latest investigations on the effects of pharmacological treatments in relation to and dependent on age, gender, fat mass and disease status. Therefore and importantly, this volume reviews the latest data on how pharmacotherapy has to be adjusted and personalized in regards to stages of development and during the pediatric lifespan from neonate through adolescence. In addition, the topic of rare diseases and special challenges for pharmacotherapy will be included and will provide readers with the necessary knowledge to handle complex diseases and treatment strategies especially in relation to pharmacotherapy of rare and orphan diseases.

The sixth edition of PharmacyPractice brings the contents completely up to date, reflecting emerging new roles for pharmacists both within the traditional employment areas of hospital and community pharmacy, as well as other developing roles supporting the public health agenda, governance, risk management, prescribing and pharmaco-economics. Each chapter begins with Study Points and ends with Key Points to reinforce learning. Appendices include medical abbreviations, Latin terms and abbreviations, systems of weights and measurements and presentation skills. Some chapters also carry self-assessment questions for more complex areas of pharmaceutical practice. New editor on the team, Louise Cogan. Many new contributors, comprising practising pharmacists, teachers of pharmacy, and pharmacists with joint appointments between hospital/community pharmacy and universities. Now with companion e-book included on StudentConsult New chapters on Consent History Taking/ Gathering Information Advice giving and the pharmacist as a Health Trainer Using calculations in pharmacy practice Continuing professional development and revalidation Intra and inter professional working, The role of the pharmacist in medicines optimization

The scope of nanotechnology in medical applications has expanded fast in the last two decades. With their unprecedented material properties, nanoscale materials present with unorthodox opportunities in a wide range of domains, including drug delivery and medical imaging. This book assembles the various facets of nanomedicine while discussing key issues such as physicochemical properties that enhance the appeal of nanomedicine.The book is an excellent resource for physicians, PhDs, and postdocs involved in nanomedicine research to learn and understand the scope and complexity of the subject. It begins with a short history of nanotechnology, followed by a discussion on the fundamental concepts and extraordinary properties of nanoscale materials, and then slowly unfolds into multiple chapters illustrating the uses of various nanomaterials in drug delivery, sensing, and imaging.

The March 2020 British National Formulary (BNF 79) is your essential reference book for prescribing, dispensing, and administering medicines.

The internationally best-selling Medical Pharmacology at a Glance is the ideal companion for all medical and healthcare students, providing a visual overview of pharmacology, and describing the basic principles of drug action, interaction, absorption, and excretion. Clear and accessible chapters organised around common diseases and conditions facilitate efficient clinical learning, and include references to drug classes and side effects, disease pathophysiology, prescribing guidelines, and more. Now in its ninth edition, this leading guide has been thoroughly updated to reflect current guidelines and drug information. This edition features new and revised illustrations, additional pedagogical tools, and enhanced online content. Widely recognised as both the best introduction to medical pharmacology and the perfect revision tool for USMLE and pharmacology exams, this invaluable guide: Covers a wide range of drugs used to treat conditions such as hypertension, anaemias, cancer, and affective disorders Explains drug mechanisms and the principles of drug action Discusses practical topics including drug misuse, drug indications, and side effects Includes a companion website featuring online cases, flashcards, and a list of core drugs

This book covers the latest environmental issues based on current research objectives. All chapters are fundamentally interlinked and focus on deciphering the networking of mutagens in environmental toxicity and human health. Our changing environment, climate, and lifestyle factors are growing concerns in the 21st century. The existing mutagens, either physical or chemical, are responsible for environmental toxicity. These toxicants are carcinogenic and not limited to naturally occurring chemicals or biologicals, but can also be man-made, such as'radiation'. The networking of mutagens can have a broad range of effects on both the environment and human health. Accordingly, the respective chapters explore the networking of mutagens in connection with environmental toxicity, and address: 1. Extant types of man-made radiation and their effects on the environment and biological systems2. Heavy metal contaminations: Effects on environmental health3. Networking of environmental pollutants in the air, dust, soil, water, and natural toxins in the environment: Exposure and health4. The molecular interaction of environmental carcinogens with DNA: An oncoinformatics approach5. Fundamentals of nonotoxicity, carcinogenicity, mutagenic and neurotoxicity in environmental health6. The role of antioxidants and medicinal plants in reducing the impacts of disease-causing pollutants A sequel to Perspectives in Environmental Toxicology, this book highlights the latest developments in the field of environmental toxicology. It offers a valuable resource for researchers, scholars and graduate students alike.

Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 41, first published in 1977, and continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs, presents clinicians and medical investigators with a critical survey of new data and trends in adverse drug reactions and interactions. Topics covered in this new release include Central Nervous System Stimulants and Drugs that Suppress Appetite, Antidepressants, Lithium, Drugs of Abuse, Hypnotics and Sedatives, Antipsychotic Drugs, Antiepileptics, Opioid Analgesics and Narcotic Antagonists, Anti-Inflammatory and Antipyretic Analgesics and Drugs Used in Gout, and much more. - Provides a critical yearly survey of the new data and trends regarding the side effects of drugs - Authored and reviewed by worldwide pioneers in the clinical and practice sciences - Presents an essential clinical guide on the side effects of drugs for practitioners and healthcare professionals alike

'The very last thing a drug regulator wishes to be able to say is, like Lord Byron (1788-1824), on the publication of his poem Childe Harold's Pilgrimage,'I awoke one morning and found myself famous.'The twelfth edition of this long-established textbook of clinical pharmacology (first published in 1960) continues its fine tradition of balancing science and practice for improved evidence-based drug therapy and good prescribing in therapeutic settings increasingly complicated by intercurrent disease and polypharmacy. - Coverage of all major therapeutic topics by body system. - Introductory sections give brief chapter synopses. - Case studies where relevant. - Covers the needs of the developing world with a focus on practical prescribing and health technology assessment. - Definition, tips, brief explanation boxes throughout. - Interesting histories, etymologies and provenances of terms throughout. - Entertaining footnotes throughout. - Fully updated throughout. - New co-editor: Fraz Mir, Addenbrooke's Hospital and Department of Medicine, University of Cambridge. - Now with free e-book on StudentConsult.

Now over 70,000 copies sold! This comprehensively revised edition of Clinical Biochemistry offers essential reading for today's students of medicine and other health science disciplines – indeed, anyone who requires a concise, practical introduction to the subject. Topics are clearly presented in a series of double-page ‘learning units', each covering a particular aspect of clinical biochemistry. Four sections provide a core grounding in the subject: Introducing clinical biochemistry gives an insight into how modern hospital laboratories work, and includes an entirely new series of learning units on the interpretation of test results Core biochemistry covers the bulk of routine analyses, and their relevance to the clinical setting Endocrinology provides an overview of endocrine investigations as well as a practical approach to thyroid, adrenal, pituitary and gonadal function testing Specialised investigations embraces an assortment of other topics that students may encounter This edition represents the most radical revision of the book to date. Every learning unit has been examined and updated to reflect current developments and clinical best practice. Entirely new material includes a series of learning units on interpretation and analytical aspects of clinical biochemistry. Coverage of fluid biochemistry is now more comprehensive. New'Want to know more?'links throughout the book point readers to relevant further information. (Printed version) now includes the complete eBook version for the first time – downloadable for anytime access and enhanced with new, interactive multiple choice questions for each section, to test your understanding and aid exam preparation

The BNF for Children (BNFC) 2019-2020 provides essential practical information to all healthcare professionals involved in the prescribing, dispensing, monitoring and administration of medicines to children. It addresses a significant knowledge gap in many areas of paediatric practice by providing practical information on the use of medicines in children of all ages from birth to adolescence. Recommendations in the BNFC have been constructed on the basis of authoritative sources, emerging evidence and best practice guidelines. The content has been carefully validated by a network of paediatric experts and the process is overseen by a paediatric formulary committee. The BNF for Children 2018-2019 has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice.

New methods, new approaches and advanced technologies have started to be used for patients to gain access to less costly and more quality diagnosis and treatment services in a shorter time. This book, which includes new approaches in health sciences, has been written by successful and expert researchers who work in different health disciplines of health sciences.

The March 2019 British National Formulary (BNF 77) is your essential reference book for prescribing, dispensing, and administering medicines.

Drugs in Sport is the most comprehensive and accurate text on the emotive, complex and critical subject of doping and illegal performance enhancement in sport. Thoroughly updated in light of the latest World Anti-Doping Code and taking into account the latest regulations, methods and landmark cases, this seventh edition explores the science behind drug-use in sport, as well as its ethical, social, political and administrative context. Introducing an increased focus on inadvertent doping, athlete-support personnel as key stakeholders in the doping process, societal drug-use, and the role of national governing bodies and anti-doping organisations, the book covers key topics including: an assessment of the prevalence of drug-taking in sport the latest doping control regulations stipulated by the World Anti-Doping Agency (WADA) the science and side effects of each major class of drug used in sport cutting-edge issues such as gene doping and biological passports issues surrounding legal substances and ergogenic aids in supplements medical and pharmaceutical services at major sporting events Accessibly written, and supported throughout with illustrative case studies and data, Drugs in Sport provides a crucial and objective resource for students and researchers, athletes, sports scientists, coaches and athlete-support staff, journalists, sports administrators and policymakers, alike.

Avec plus de 4600 spécialités et 4000 produits de parapharmacie pour cette 94e édition, le Dictionnaire VIDAL constitue l'ouvrage indispensable des professionnels de Santé dans le cadre de leur pratique quotidienne. Les monographies VIDAL sont rédigées d'après les données publiées par l'Agence nationale de sécurité du médicament et des produits de santé (Ansm), en particulier les Résumés des caractéristiques du produit (RCP), et les informations économiques publiées au Journal officiel. Toutes structurées de la même façon, les monographies permettent une lecture rapide et pratique. Elles sont le reflet de l'information officielle disponible au moment de la publication du Dictionnaire.

The over-arching goal of this volume is to help infertility practitioners evaluate and manage their patients with poor semen quality. The authors review the existing literature on the effects of medications on male fertility, and provide detailed information about what is known, giving the number of individuals and population characteristics for studies of medication effects on male fertility. Medications are designed to treat illness and reduce symptoms, but all have undesirable adverse effects such as headache or stomach upset. Some adverse reactions can even be life-threatening, so it is no surprise that some drugs have negative effects on male reproduction. Medical practitioners rarely consider a man's reproductive plans when prescribing medications. Men are routinely treated with drugs that can impair or abolish fertility.Although practitioners in the field of reproductive medicine generally realize that certain drugs impact negatively on reproductive health, thereare limited resources providing evidence-based knowledge useful in counseling patients. Tables throughout this volume summarize the information for each drug, providing a handy reference for clinical use.

The September 2018 British National Formulary (BNF 76) is your essential reference book for prescribing, dispensing, and administering medicines.

Pharmacy Registration Assessment Questions 2 follows on from the previous, highly popular Pharmacy Registration Assessment Question. If features more than 400, entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All the questions are in line with current GPhC guidance on the preregistration exam. This invaluable tool will not only help you familiarise yourself with the current style of questions, but will also enable you to revise ahead of your exams.Questions are based on BNF74 and BNF for Children 2017-2018, alongside the most current treatment guidelines available at the time of writing the book. This book also includes questions featuring prescriptions, patient information and pictorial representation of conditions, replicating the type of questions you may encounter in the real exam. This revision aid gives you the opportunity to practice a variety of question styles ahead of the assessment including:single best answer questionsextended matching questionscalculationsThis volume is written by a team of experienced authors who all work with pre-reg pharmacists every day and includes questions that are practical and will truly challenge you. In essence, this book is your handy guide to prepare for your exams. Nadia Bukhari is Senior Teaching Fellow in Pharmacy Practice & Pre-Registration Co-ordinator at the UCL School of Pharmacy. She is also the chairwoman for the Royal Pharmaceutical Society Pre-Registration conferences.

A unique compilation of expertise on anatomy, physiology, clinical issues, and current research, this textbook analyzes the range of presentation with age, ethnicity, symptoms, disorders, diagnoses, and toxicity. The second edition of this essential resource for anyone taking care of female patients has been doubled in scope to include additional chapters. All physicians, whether dermatologists or gynaecologists, as well as those researching the scientific evidence and symptoms, will benefit from the experience of the expert contributors and editors gathered here.

Prescribing for children is a particularly challenging discipline due to specific issues of drug absorption, metabolism, distribution and excretion. The aim of this book is to improve understanding in all aspects of paediatric prescribing, from the development of suitable drugs through to their practical administration.

The March 2018 British National Formulary (BNF 75) is your essential reference book for prescribing, dispensing, and administering medicines.

The BNF for Children (BNFC) 2018-2019 provides essential practical information to all healthcare professionals involved in the prescribing, dispensing, monitoring and administration of medicines to children. It addresses a significant knowledge gap in many areas of paediatric practice by providing practical information on the use of medicines in children of all ages from birth to adolescence. Recommendations in the BNFC have been constructed on the basis of authoritative sources, emerging evidence and best practice guidelines. The content has been carefully validated by a network of paediatric experts and the process is overseen by a paediatric formulary committee. The BNF for Children 2018-2019 has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice.

BNF 73 (March 2017) is the authoritative guide to prescribing, dispensing and administering medicines for all healthcare professionals.

BNF 74 has been compiled with the advice of clinical experts and continually updated to reflect the latest evidence from credible sources worldwide. It provides up-to-date guidance on prescribing, dispensing, and administering medicines. Access to the latest edition of the BNF is vital for healthcare professionals, as it reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.

The BNF for Children (BNFC) 2017-2018 provides essential practical information to all healthcare professionals involved in the prescribing, dispensing, monitoring and administration of medicines to children. It has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice. The resource addresses a significant knowledge gap in many areas of paediatric practice by providing practical information on the use of medicines in children of all ages from birth to adolescence.

Avec plus de 4600 spécialités et 4000 produits de parapharmacie pour cette 93e édition, le Dictionnaire VIDAL constitue l'ouvrage indispensable des professionnels de Santé dans le cadre de leur pratique quotidienne. Les monographies VIDAL sont rédigées d'après les données publiées par l'Agence nationale de sécurité du médicament et des produits de santé (Ansm), en particulier les Résumés des caractéristiques du produit (RCP), et les informations économiques publiées au Journal officiel. Toutes structurées de la même façon, les monographies permettent une lecture rapide et pratique. Elles sont le reflet de l'information officielle disponible au moment de la publication du Dictionnaire.